MKI67 and breast carcinoma: In the treatment of breast cancer, Ki-67 is regarded as a predictive marker for the efficacy of chemotherapy, and the decision to administer adjuvant chemotherapy is frequently determined on the basis of the Ki-67 proliferation index [3].